Insulet (PODD) Shares Repurchased (2018 - 2026)

Insulet (PODD) reported Shares Repurchased of $300.0 million for Q1 2026, up 916.95% quarter-over-quarter from $29.5 million in Q3 2025.

Insulet (PODD) Shares Repurchased (2018 - 2026) Analysis & Trends

Insulet has reported Shares Repurchased for 4 years, with the latest figure at $300.0 million in Q1 2026.

For the quarter ending Q1 2026, Shares Repurchased changed N/A year-over-year to $300.0 million; the trailing twelve-month figure through Mar 2026 stood at $359.6 million (up 119766.67% YoY), and the FY2025 full-year result was $59.6 million, changed N/A from the prior year.
Shares Repurchased for Q1 2026 stood at $300.0 million, up from $29.5 million in the prior quarter.
The five-year high for Shares Repurchased was $300.0 million in Q1 2026, with the low at $29.5 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Repurchased (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn	180.00 Mn
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn	-
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn	105.00 Mn
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn	-
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn	421.80 Mn
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn	100.00 Mn
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn	-
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn	74.30 Mn
10	Insulet	10.47 Bn	9.99 Bn	529.10 Mn	300.00 Mn

Download Data